Abstract:Jia-hui Rong, 1 Dong Li, 2 Yu-liang Li 2 1 Department of Cardiology, The Second Hospital of Shandong University, Jinan, People's Republic of China; 2 Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, People's Republic of China Correspondence: Dong Li; Yu-liang Li Department of Interventional Medicine, The Second Hospital of Shandong University, 247 Beiyuan Street, Jinan 250000, People's Republic of China Email 714048127@qq.com; lyl.pro@sdu.edu.cn Introduction: In recent years, radioactive 125 I seed implantation combined with chemotherapy has been regarded as a safe and effective treatment for advanced non-small cell lung cancer (NSCLC). However, the mechanism underlying this success is still unclear. Methods: In this study, we investigated the apoptosis and anti-proliferative effect induced by 125 I in A549, H1975, and H157 cells and determined whether a sensitizing concentration of lobaplatin (LBP) could enhance these effects. We performed in vitro experiments on A549, H1975, and H157 cells; we investigated the effects of 125 I or lobaplatin (LBP) alone, or in combination, on cellular apoptosis and proliferation by performing flow cytometry, Bax/Bcl2 ratio, TUNEL, cell viability assay, cell cycle, and EdU. To further verify our findings, a subcutaneous tumor mouse model was established. Moreover, AKT/mTOR pathway was detected to determine whether this pathway was involved in the anti-cancer effect of 125 I and LBP by up-regulating or down-regulating the expression of mTOR. Results: Based on our results, the sensitizing concentration of LBP could enhance the 125 I-induced apoptosis and anti-proliferation effect. Furthermore, the subcutaneous tumor mouse model obtained the consistent results. More importantly, the AKT/mTOR pathway was down-regulated after the treatment of 125 I and LBP, and the anti-cancer effect of 125 I and LBP could be compromised by up-regulating the mTOR expression. Conclusion: Our study proved that LBP promotes the apoptotic and anti-proliferative effects of 125 I in NSCLC cells by inhibiting the AKT/mTOR pathway and provides a foundation for future studies and enhanced combinatorial approaches for NSCLC in the clinical setting. Keywords: radioactive 125 I seed, lobaplatin, non-small cell lung cancer, apoptosis, proliferation, AKT/mTOR pathway

Lobaplatin for the Treatment of SK-MES-1 Lung Squamous Cell Line in Vitro and in Vivo

Lobaplatin Suppresses Proliferation and Peritoneal Metastasis of Colorectal Cancer in a Preclinical Model

Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer Sk-Mes-1 Cells

Lobaplatin Promotes Radiosensitivity, Induces Apoptosis, Attenuates Cancer Stemness and Inhibits Proliferation Through PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma

Lobaplatin Arrests Cell Cycle Progression in Human Hepatocellular Carcinoma Cells

Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.

Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.

Antitumor Activity of Lobaplatin Alone or in Combination with Antitubulin Agents in Non-Small-cell Lung Cancer

Lobaplatin Inhibits Growth of Gastric Cancer Cells by Inducing Apoptosis

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer.

Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway

Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.

Preclinical Activity of Lobaplatin As a Single Agent and in Combination with Taxanes for Ovarian Carcinoma Cells.

Ecliptasaponin A induces apoptosis through the activation of ASK1/JNK pathway and autophagy in human lung cancer cells.

Lobaplatin Enhances Radioactive 125I Seed-Induced Apoptosis and Anti-Proliferative Effect in Non-Small Cell Lung Cancer by Suppressing the AKT/mTOR Pathway

Lobetyol Activate MAPK Pathways Associated with G1/S Cell Cycle Arrest and Apoptosis in MKN45 Cells in Vitro and in Vivo.

Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.

The inhibitory effects of lobaplatin, or in combination with gemcitabine on triple-negative breast cancer cells<i> in</i><i> vitro</i> and<i> in</i><i> vivo</i>

Preclinical Pharmacodynamic Evaluation of Drug Candidate Sklb-178 in the Treatment of Non-Small Cell Lung Cancer

Isoalantolactone Induces Intrinsic Apoptosis Through P53 Signaling Pathway in Human Lung Squamous Carcinoma Cells.